Nephrostomy Devices Market Size, Share, Growth Analysis, 2032

Nephrostomy Devices Market: Industry Perspective

The global nephrostomy devices market size was worth around USD 1191.74 Million in 2023 and is predicted to grow to around USD 2450.65 Million by 2032 with a compound annual growth rate (CAGR) of roughly 8.34% between 2024 and 2032. The report analyzes the global nephrostomy devices market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the nephrostomy devices industry.

Request Free Sample

The report covers forecast and analysis for the Nephrostomy Devices market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million). The study includes drivers and restraints for the Nephrostomy Devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Nephrostomy Devices market on a global level. In order to give the users of this report a comprehensive view of the Nephrostomy Devices market we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Product, End-user, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

Request Free Sample

Nephrostomy Devices Market: Overview

An opening between the kidney and the skin is a nephrostomy. A nephrostomy tube is a thin plastic tube that passes through the leg, through the body, and then through the kidney to the point where the urine is collecting. His task is to clear the blocked urine temporarily. This enables proper functioning of the kidney and protects it against further damage. It also helps to clear up any infection. The procedure is guided by ultrasound and/or X-ray images (or images). Contrast is injected into the urine-collecting part of the kidney. This allows the tube that drains the kidney to be placed in the best position in the collection system. Nephrostomy catheter placement is usually performed in the radiology room or operating room by interventional radiologists under image guidance.

Cancers of reproductive organs such as ovarian cancer, colon cancer, etc. are the most common cause of nephrostomy. Dilation catheters are the latest solution to percutaneous dilation challenges. Though contraindicated in pregnant women, for selected patients who develop symptoms of urolithiasis during childbirth, percutaneous nephrostomy is recommended. Other indications of recommended nephrostomy include infections of the urinary tract, bladder prolapse, hyperplasia of the benign prostate, urinary incontinence, etc.

Nephrostomy Devices Market: Growth Factors

Increasing popularity is also driving the market for minimally invasive procedures. In addition, increasing lifestyle-related disorder cases are likely to contribute to the development of the industry. Already shaping the global market is developing healthcare infrastructure in emerging economies. Nephrostomy catheters are commonly used to clear a device that collects blocked urine. This blockage results in hydronephrosis, which is performed with the aid of catheters of nephrostomy. As a result, the increase in the number of hydronephrosis is expected to boost catheter demand, fueling market growth in nephrostomy devices. It is also projected that rising cases of lung, ovarian, and prostate cancer will have a positive impact on consumer demand over the forecast years. Another key driver is the increasing incidence of post-operative infections in kidney transplant patients.

Nephrostomy Devices Market: Segmentation Analysis

The study provides a decisive view of the Nephrostomy Devices market by segmenting the market based on Product, End-user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on Product, the market is segmented into guidewires, drainage tubes, nephrostomy catheters, sheath dilators and others. Due to the less invasive nature of the product, the Guidewires segment is expected to hold maximum market share in the forecast period population and the prevalence of urinary and bladder disorders is expected to increase consumer demand, thereby affecting segment growth. Guidewire manufacturers focus on working with healthcare providers to increase their customer base and strengthen their position in the industry. Therefore, these manufacturers' initiatives and the emergence of well-established and professional practitioners in developed economies are expected to increase demand for guidewires. Technological advances in nephrostomy devices, such as the introduction of balloon dilation catheters with original multilayer technology, are expected to provide the market with lucrative opportunities.

Based on the End user segment, the market is bifurcated into Hospitals, Emergency Clinics, Ambulatory Surgical Centers (ASCs) and others. As they offer more tailored services, ambulatory surgical centers (ASCs) are likely to observe the fastest CAGR from 2024 to 2032. In addition, the category is also powered by better results relative to hospitals and other healthcare settings. During surgery in ASCs, the risk of infection is half that of hospitals, which also helps boost the growth of the segment. Furthermore, ASCs ensure that patients receive tailored service with improved patient experience, as they are not challenged to treat various types of diseases and disorders.

Nephrostomy Devices Market: Regional Insights

The geographical segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The largest share in the past was in North America. Due to positive reimbursement policies, improved product awareness, the availability of highly skilled physicians and the presence of well-established healthcare facilities in the region, it is expected to see significant growth in the future as well. It is also expected that the quick adoption of technologically advanced medical products will drive the region's market. Rising government funding for R&D activities in surgical devices and procedures also has a positive impact on growth in the regional market. From 2024 to 2032, Asia Pacific is expected to grow at the highest CAGR due to increasing cases of kidney disorders, supportive government initiatives, and numerous NGO programs to raise awareness of the drug. In addition, the presence of a large number of key companies in China and India leads to the development of the industry. It is further expected that the rapidly expanding medical tourism market in Asia Pacific's developing economies will increase product demand, thereby growing market growth.

Nephrostomy Devices Market: Report Scope

Nephrostomy Devices Market: Competitive Space

• Boston Scientific Corp.
• Teleflex
• Cardinal Health
• Becton
• Dickinson and Company
• Cook Medical
• B. Braun Melsungen AG
• Coloplast Group
• Olympus Corp.
• Argon Medical
• Uresil LLC amongst others.

Nephrostomy Devices Market: Competitive Analysis

Some of the major players in the global nephrostomy devices market include:

Global Nephrostomy Devices Market: Product Segment Analysis

• Guidewires
• Drainage Tubes
• Nephrostomy Catheters
• Sheath Dilators
• Others

Global Nephrostomy Devices Market: End-user Segment Analysis

• Hospital
• Emergency Clinics
• Ambulatory Surgical Center
• Others

Global Nephrostomy Devices Market: Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa